GlassScriptPhysician profile
Brittany L Andersen
NPI 1104324698
$2,586.68
in general payments reported to CMS, 2019-2025
19 companies · $677 in 2025
The $677 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $291 · 2023: $429 · 2024: $1,047 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,969.88 |
| Education | $182.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $726.95 | 2023-2025 | Tremfya, Stelara, Simponi |
| Abbvie INC. | $591.22 | 2022-2025 | |
| Kerecis Limited | $259.66 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Incyte Corporation | $243.93 | 2024-2025 | Opzelura |
| Organogenesis INC. | $224.18 | 2021-2022 | |
| Smith+Nephew, INC. | $80.51 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $59.27 | 2024-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $58.59 | 2021-2023 | Xarelto |
| Sun Pharmaceutical Industries INC. | $58.51 | 2025 | |
| Saranas, INC. | $44.24 | 2022 | |
| Novartis Pharmaceuticals Corporation | $42.93 | 2024-2025 | |
| Tactile Systems Technology INC | $38.22 | 2023 | Entre Plus, Flexitouch Plus |
| Medtronic, INC. | $30.55 | 2022 | |
| Amgen INC. | $26.31 | 2025 | Otezla |
| Ucb, INC. | $24.37 | 2025 | Bimzelx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $22.35 | 2025 | Sofdra |
| Biofrontera INC. | $20.16 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Galderma Laboratories, L.P. | $19.90 | 2025 | Aklief |
| Genzyme Corporation | $14.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.